Rivaroxaban versus low-molecular-weight heparin and fondaparinux for preventing deep vein thrombosis after total knee arthroplasty in high-altitude residents: a randomized controlled trial

Liangjuan Ren, Hongxia Fang, Xiaoqin Fu, Xin Chu, Xinjun Liu, Lihan Shi, Pai Zheng · 2026

Read Rivaroxaban versus low-molecular-weight heparin and fondaparinux for preventing deep vein thrombosis after total knee arthroplasty in high-altitude residents: a randomized controlled trial by Liangjuan Ren, Hongxia Fang, Xiaoqin Fu, Xin Chu, Xinjun Liu, Lihan Shi, Pai Zheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471297.txt.

Description

Ren and colleagues randomized 90 knee replacement patients in 2026 who live at high altitude, comparing three blood thinners for preventing deep vein clots after surgery. Thin air above 1,500 meters thickens the blood and raises clot risk. Patients received the oral drug rivaroxaban, injected heparin, or injected fondaparinux. Ultrasound on day 14 checked for clots. Blood markers of clotting and inflammation were tracked, along with bleeding events.

The oral drug won outright. No rivaroxaban patient developed a clot, against about 17 percent on heparin and about 13 percent on fondaparinux. A clot breakdown marker, D-dimer, also ran significantly lower with rivaroxaban by day 14. Two inflammation markers fell further on the oral drug than on either injection. Blood loss during surgery and bleeding complications matched across all three groups. The authors conclude that a simple daily pill protects high-altitude patients best after knee replacement, without extra bleeding.

Catalog record

CREATORLiangjuan Ren, Hongxia Fang, Xiaoqin Fu, Xin Chu, Xinjun Liu, Lihan Shi, Pai Zheng
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13471297

Browse the full library · About the Tower of Babel